Mitiglinide calcium

This classification denotes an anti-diabetic agent with the molecular formula 2C19H24NO3.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P5WOR98G68, chemically known as (s)-2-benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)butyric acid calcium salt, but more generally known as mitiglinide calcium, which bears US NIH Compound Identifier 5478927. European Medicines Agency schedules mitiglinide calcium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08999MIG. Most nations, for tariff purposes, schedule mitiglinide calcium under HS 29339990. SMILES: C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].C1CCC(CC1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-].[CA+2].